BÁLEK, Lukáš, Marcela BUCHTOVÁ, Michaela BOSÁKOVÁ, Miroslav VAŘECHA, Silvie TRANTÍRKOVÁ, Iva GUDERNOVÁ, Iva VESELÁ, Jan HAVLIK, Jitka NEBURKOVA, Stuart TURNER, Mateusz Adam KRZYSCIK, Malgorzata ZAKRZEWSKA, Lars KLIMASCHEWSKI, Peter CLAUS, Lukáš TRANTÍREK, Petr CIGLER and Pavel KREJČÍ. Nanodiamonds as "artificial proteins": Regulation of a cell signalling system using low nanomolar solutions of inorganic nanocrystals. Biomaterials. OXFORD: ELSEVIER SCI LTD, 2018, vol. 176, SEP 2018, p. 106-121. ISSN 0142-9612. Available from: https://dx.doi.org/10.1016/j.biomaterials.2018.05.030.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Nanodiamonds as "artificial proteins": Regulation of a cell signalling system using low nanomolar solutions of inorganic nanocrystals
Authors BÁLEK, Lukáš (203 Czech Republic, belonging to the institution), Marcela BUCHTOVÁ (203 Czech Republic, belonging to the institution), Michaela BOSÁKOVÁ (203 Czech Republic, belonging to the institution), Miroslav VAŘECHA (203 Czech Republic, belonging to the institution), Silvie TRANTÍRKOVÁ (203 Czech Republic, belonging to the institution), Iva GUDERNOVÁ (203 Czech Republic, belonging to the institution), Iva VESELÁ (203 Czech Republic, belonging to the institution), Jan HAVLIK (203 Czech Republic), Jitka NEBURKOVA (203 Czech Republic), Stuart TURNER (56 Belgium), Mateusz Adam KRZYSCIK (616 Poland), Malgorzata ZAKRZEWSKA (56 Belgium), Lars KLIMASCHEWSKI (40 Austria), Peter CLAUS (276 Germany), Lukáš TRANTÍREK (203 Czech Republic, belonging to the institution), Petr CIGLER (203 Czech Republic) and Pavel KREJČÍ (203 Czech Republic, guarantor, belonging to the institution).
Edition Biomaterials, OXFORD, ELSEVIER SCI LTD, 2018, 0142-9612.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30404 Biomaterials
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 10.273
RIV identification code RIV/00216224:14110/18:00101655
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.biomaterials.2018.05.030
UT WoS 000437038400010
Keywords in English Nanodiamonds; Cell signalling; FGF; Fibroblast growth factor; Nanotherapeutics
Tags 14110513, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Marie Šípková, DiS., učo 437722. Changed: 20/4/2022 12:40.
Abstract
The blocking of specific protein-protein interactions using nanoparticles is an emerging alternative to small molecule-based therapeutic interventions. However, the nanoparticles designed as "artificial proteins" generally require modification of their surface with (bio)organic molecules and/or polymers to ensure their selectivity and specificity of action. Here, we show that nanosized diamond crystals (nanodiamonds, NDs) without any synthetically installed (bio)organic interface enable the specific and efficient targeting of the family of extracellular signalling molecules known as fibroblast growth factors (FGFs). We found that low nanomolar solutions of detonation NDs with positive-potential strongly associate with multiple FGF ligands present at sub-nanomolar concentrations and effectively neutralize the effects of FGF signalling in cells without interfering with other growth factor systems and serum proteins unrelated to FGFs. We identified an evolutionarily conserved FGF recognition motif, 17 amino acids long, that contributes to the selectivity of the ND-FGF interaction. In addition, we inserted this motif into a de novo constructed chimeric protein, which significantly improved its interaction with NDs. We demonstrated that the interaction of NDs, as purely inorganic nanoparticles, with proteins can mitigate pathological FGF signalling and promote the restoration of cartilage growth in a mouse limb explant model. Based on our observations, we foresee that NDs may potentially be applied as nano therapeutics to neutralize disease-related activities of FGFs in vivo. (C) 2018 The Authors. Published by Elsevier Ltd.
Links
GA17-09525S, research and development projectName: Neobvyklé signální dráhy lidských receptorových tyrozinových kináz
Investor: Czech Science Foundation
GA17-12075S, research and development projectName: Polymorfní G-quadruplexy v promotorových oblastech genů
Investor: Czech Science Foundation
LH15231, research and development projectName: Nové mechanismy vzniku fatálních kostních ciliopatií u člověka
Investor: Ministry of Education, Youth and Sports of the CR
LQ1601, research and development projectName: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
NV15-33232A, research and development projectName: Identifikace nových možností léčby achondroplásie prostřednictvím analýzy interakce FGFR3 a adaptérového proteinu Frs2
NV15-34405A, research and development projectName: Identifikace nových možností léčby chronické myeloidní leukémie pomocí systematické analýzy interaktomu proteinu BCR-ABL
PrintDisplayed: 5/7/2024 08:23